Every day, more than 1 million people are newly infected with sexually transmitted infections (STIs) that can lead to morbidity, mortality, and an increased risk of human immunodeficiency virus (HIV) acquisition. Existing prevention and management strategies, including behavior change, condom promotion, and therapy have not reduced the global incidence and prevalence, pointing to the need for novel innovative strategies. This review summarizes important issues raised during a satellite session at the first HIV Research for Prevention (R4P) conference, held in Cape Town, on October 31, 2014. We explore key STIs that are challenging public health today, new biomedical prevention approaches including multipurpose prevention technologies (MPTs)...
HIV spread has reached a turning point following decades of increasing and sustained incidence. An e...
Nearly 1 million people become infected every day with any of the four major curable sexually transm...
Infections with the human immune deficiency virus (HIV) remain an important health issue. In Europe ...
Every day, more than 1 million people are newly infected with sexually transmitted infections (STIs)...
It is estimated that more than one million people acquire an STI every day. Each STI on its own repr...
BackgroundContinued high incidence of HIV and other STIs, paired with rising antibiotic resistance t...
ObjectiveMultipurpose prevention technologies (MPTs) are an innovative class of products that delive...
AbstractObjectivesWorldwide, women face sexual and reproductive health (SRH) risks including uninten...
Sexually transmitted infections remain to be of public health concern in many developing countries. ...
Women worldwide confront two frequently concurrent reproductive health challenges: the need for cont...
Background The ideal vaginal microbicide should reduce the risk of HIV infection and other reproduct...
We have entered a new era in HIV prevention whereby priorities have expanded from biomedical discove...
This brief describes multipurpose prevention technologies (MPTs) that address women\u27s sexual and ...
This paper presents the public health rationale for multipurpose prevention technologies (MPTs) for ...
HIV spread has reached a turning point following decades of increasing and sustained incidence. An e...
HIV spread has reached a turning point following decades of increasing and sustained incidence. An e...
Nearly 1 million people become infected every day with any of the four major curable sexually transm...
Infections with the human immune deficiency virus (HIV) remain an important health issue. In Europe ...
Every day, more than 1 million people are newly infected with sexually transmitted infections (STIs)...
It is estimated that more than one million people acquire an STI every day. Each STI on its own repr...
BackgroundContinued high incidence of HIV and other STIs, paired with rising antibiotic resistance t...
ObjectiveMultipurpose prevention technologies (MPTs) are an innovative class of products that delive...
AbstractObjectivesWorldwide, women face sexual and reproductive health (SRH) risks including uninten...
Sexually transmitted infections remain to be of public health concern in many developing countries. ...
Women worldwide confront two frequently concurrent reproductive health challenges: the need for cont...
Background The ideal vaginal microbicide should reduce the risk of HIV infection and other reproduct...
We have entered a new era in HIV prevention whereby priorities have expanded from biomedical discove...
This brief describes multipurpose prevention technologies (MPTs) that address women\u27s sexual and ...
This paper presents the public health rationale for multipurpose prevention technologies (MPTs) for ...
HIV spread has reached a turning point following decades of increasing and sustained incidence. An e...
HIV spread has reached a turning point following decades of increasing and sustained incidence. An e...
Nearly 1 million people become infected every day with any of the four major curable sexually transm...
Infections with the human immune deficiency virus (HIV) remain an important health issue. In Europe ...